Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (third of three parts).
D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D000818:Animals; D000986:Antisickling Agents / Q000494:pharmacology / Q000627:therapeutic use; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005740:Gases / Q000494:pharmacology; D005782:Gels; D006451:Hemoglobin, Sickle / Q000032:analysis; D006801:Humans; D008403:Mass Screening; D010100:Oxygen / Q000097:blood; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011935:Reagins / Q000494:pharmacology
D000986:Antisickling Agents; D005740:Gases; D005782:Gels; D006451:Hemoglobin, Sickle; D011935:Reagins; D010100:Oxygen